Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03355508
Other study ID # TECHFAVHEMO
Secondary ID
Status Recruiting
Phase N/A
First received October 25, 2017
Last updated November 21, 2017
Start date September 29, 2017
Est. completion date February 2021

Study information

Verified date October 2017
Source Poissy-Saint Germain Hospital
Contact Loizeau Valerie
Phone 0139274727
Email vloizeau@chi-poissy-st-germain.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

40000 patients are hemodialysis each year in France .

In the case of chronic care, 78% of patients have an arteriovenous fistula. In order to perform the hemodialysis session, 2 techniques of puncture of the fistula are possible:

- Bevel puncture upwards then flipping the needle

- or puncture bevel down. At present, there is no consensus or study on the technique of puncture fistula which generates different professional practices.


Recruitment information / eligibility

Status Recruiting
Enrollment 42
Est. completion date February 2021
Est. primary completion date September 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Patient in chronic renal failure treated by hemodialysis with native arteriovenous fistula as a vascular approach.

- Adult of age and sex indifferent.

- Normal puncture of the fistula with two needles (bipuncture).

- Fistula use for more than 3 months.

- Beneficiary of Medicare or State Medical Aid.

- No opposition to participation in the study.

Exclusion Criteria:

- Patient who does not speak and does not understand French.

- Hemodialysis patient awaiting a transplant by a living donor.

- Patient with more than 2 AVF dilatations in the last 6 months.

- Patient with prosthetic arteriovenous fistula.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
pucture in the arteriovenous fistula
The compression time will be measured with a stopwatch so that it is objective and accurate, although the compression times range from minute to minute. An initial 2-week observation phase (phase 1) will establish a reference time for each patient using the most common puncture technique in the department: bevel up. We will evaluate the patient's reference time by counting the time of compression using a stopwatch for 2 weeks (ie 6 sessions) and we will take an average. A draw will determine for each patient the order in which the direction of the needles will be used. After this determination of the reference time, the patient will enter two successive phases where it will be punctured bevel up (phase 2) and then down (phase 3) or vice versa following the draw.

Locations

Country Name City State
France CH Poissy st Germain Poissy

Sponsors (1)

Lead Sponsor Collaborator
Poissy-Saint Germain Hospital

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Compression time required for hemostasis The primary endpoint is the compression time required for hemostasis after needle removal, which is stable over a 3-week period.
The compression time will be measured with a stopwatch so that it is objective and accurate, although the compression times range from minute to minute. An initial 2-week observation phase (phase 1) will establish a reference time for each patient using the most common puncture technique in the department: bevel up. We will evaluate the patient's reference time by counting the time of compression using a stopwatch for 2 weeks (ie 6 sessions) and we will take an average. A draw will determine for each patient the order in which the direction of the needles will be used. After this determination of the reference time, the patient will enter two successive phases where it will be tapped bevel up (phase 2) and then down (phase 3) or vice versa following the draw.
period of 3 weeks